The scarring that occurs with cirrhosis is usually irreversible, but treatment can help manage it. Causes of cirrhosis include metabolic dysfunction-associated steatotic liver disease (MASLD ...

The presence of renal dysfunction is often missed in patients with cirrhosis. Because of a reduction in muscle mass in these patients, serum creatinine may be within the normal range, even with a ...

Treatment for portal hypertension in patients with cirrhosis is based on the use of β-blockers with or without organic nitrates; however, these agents are effective in less than 50% of patients ...

Bulevirtide therapy proves effective for HDV-related cirrhosis in a 96-week real-world study, showing significant liver ...

The best way to prevent HCV is by avoiding ... If you have HCV, talk to your doctor right away to start treatment.

The FDA has granted Fast Track designation to LPCN 1148 for the treatment of sarcopenia in patients with decompensated cirrhosis.

LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...

Background and Aim: Development of overt hepatic encephalopathy (HE) is associated with poor prognosis in patients with cirrhosis. Lactulose is used for the treatment of HE. There is no study on ...

The quantitative effects of alcohol consumption on cirrhosis and hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) infection are unknown.

Patients with cirrhosis and minimal hepatic encephalopathy often experience sleep difficulties, but treatment with benzodiazepines is frequently ineffective and can have serious side effects.